Status:
COMPLETED
Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection
Lead Sponsor:
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Conditions:
COVID-19
SARS-CoV Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a double-blind, randomized, placebo-controlled clinical trial. A total of 210 individuals aged over 18 years old, without a diagnosis of severe respiratory disease, who came to the study site ...
Eligibility Criteria
Inclusion
- Suspected cases of COVID-19, due to clinical and radiological data, during the epidemic;
- Adult aged 18 or over, at the time of inclusion
- Not having severe acute respiratory syndrome (SARS), that is, not using mechanical ventilation or supplemental oxygen, peripheral oxygen saturation\> 94% in room air, and having a respiratory rate below 24 incursions per minute.
- Patients with comorbidities only, due to the increased risk of developing SARS
Exclusion
- 1\. Patients with chronic use of drugs known to prolong QTc interval.
Key Trial Info
Start Date :
April 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 8 2020
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT04342650
Start Date
April 8 2020
End Date
June 8 2020
Last Update
August 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz
Manaus, Amazonas, Brazil, 69093-415